A Coding Variant in the Gene Bardet-Biedl Syndrome 4 (BBS4) Is Associated With

Total Page:16

File Type:pdf, Size:1020Kb

A Coding Variant in the Gene Bardet-Biedl Syndrome 4 (BBS4) Is Associated With G3: Genes|Genomes|Genetics Early Online, published on May 22, 2017 as doi:10.1534/g3.117.043109 1 A Coding Variant in the Gene Bardet-Biedl Syndrome 4 (BBS4) is Associated with 2 a Novel Form of Canine Progressive Retinal Atrophy 3 Tracy Chew, *, 1 Bianca Haase, † Roslyn Bathgate, † Cali E. Willet, ‡ Maria K. Kaukonen, 4 §, **, †† Lisa J. Mascord, * Hannes T. Lohi, §, **, †† Claire M. Wade *, 1 5 6 Author Affiliations 7 *School of Life and Environmental Sciences, Faculty of Science, University of Sydney, 8 Sydney NSW Australia, †Sydney School of Veterinary Science, Faculty of Science, 9 University of Sydney, Sydney NSW Australia, ‡Sydney Informatics Hub, Core Research 10 Facilities, University of Sydney, Sydney NSW Australia, §Department of Veterinary 11 Biosciences, University of Helsinki, Finland, **Research Programs Unit, Molecular 12 Neurology, University of Helsinki, Finland, and ††Folkhälsan Institute of Genetics, 13 Finland 14 15 Reference numbers 16 Genotyping array data is available at NCBI’s Gene Expression Omnibus (accession 17 number GSE87642). Whole genome sequencing data is available at NCBI’s Sequence 18 Read Archive (BioProject accession number PRJNA344694). 19 20 1 © The Author(s) 2013. Published by the Genetics Society of America. 21 Canine Progressive Retinal Atrophy 22 23 Keywords 24 Hungarian Puli; whole genome sequencing; blindness; obesity; infertility 25 26 Corresponding authors 27 Faculty of Veterinary Science, University of Sydney, RMC Gunn Building, B19-301 28 Regimental Cres, Camperdown, NSW 2006, Australia. Email: 29 [email protected]; [email protected] 2 30 Abstract 31 Progressive retinal atrophy is a common cause of blindness in the dog and affects over 32 100 breeds. It is characterized by gradual vision loss that occurs due to the 33 degeneration of photoreceptor cells in the retina. Similar to the human counterpart 34 retinitis pigmentosa, the canine disorder is clinically and genetically heterogeneous and 35 the underlying cause remains unknown for many cases. We use a positional candidate 36 gene approach to identify putative variants in the Hungarian Puli breed using 37 genotyping data of 14 family-based samples (CanineHD BeadChip array, Illumina) and 38 whole genome sequencing data of two proband and two parental samples (Illumina 39 HiSeq 2000). A single nonsense SNP in exon 2 of BBS4 (c.58A>T, p.Lys20*) was 40 identified following filtering of high quality variants. This allele is highly associated -14 41 (PCHISQ = 3.425e , n = 103) and segregates perfectly with progressive retinal atrophy in 42 the Hungarian Puli. In humans, BBS4 is known to cause Bardet-Biedl syndrome that 43 includes a retinitis pigmentosa phenotype. From the observed coding change we expect 44 that no functional BBS4 can be produced in the affected dogs. We identified canine 45 phenotypes comparable with Bbs4-null mice including obesity and spermatozoa flagella 46 defects. Knockout mice fail to form spermatozoa flagella. In the affected Hungarian Puli 47 spermatozoa flagella are present, however a large proportion of sperm are 48 morphologically abnormal and <5% are motile. This suggests that BBS4 contributes to 49 flagella motility but not formation in the dog. Our results suggest a promising opportunity 50 for studying Bardet-Biedl syndrome in a large animal model. 3 51 Introduction 52 Progressive retinal atrophy (PRA, OMIA #000830-9615) is the most common cause of 53 hereditary blindness in the domestic dog (Canis lupus familiaris), affecting over 100 54 pure breeds (Whitley et al. 1995). It is clinically and genetically heterogeneous and 55 encompasses several forms of disease which vary by aetiology, rate of progression and 56 age of onset (Downs et al. 2014a). The typical characteristics are gradual night, 57 followed by day vision loss due to the degeneration of rod and cone photoreceptors and 58 this degeneration continues until the affected animal is completely blind (Parry 1953). 59 Ophthalmic features that become apparent as the retina deteriorates include tapetal 60 hyper-reflectivity, vascular attenuation, pigmentary changes and atrophy of the optic 61 nerve head (Parry 1953; Clements et al. 1996; Petersen-Jones 1998). 62 PRA is recognized as the veterinary equivalent of retinitis pigmentosa (RP) in humans 63 due to the clinical and genetic similarities between the disorders (Petersen-Jones 1998; 64 Cideciyan et al. 2005; Zangerl et al. 2006; Downs et al. 2011). RP is a common cause 65 of blindness in humans and affects approximately 1 in 4,000 people (Hamel 2006). 66 There are very limited treatment options for both PRA and RP at present (Hamel 2006). 67 For this reason, the dog has become a valuable large animal model for retinal 68 degeneration, in particular, for testing the efficacy of novel therapeutics such as gene 69 therapy (Pearce-Kelling et al. 2001; Acland et al. 2001; Narfström et al. 2003; Cideciyan 70 et al. 2005; Beltran et al. 2012; Pichard et al. 2016). As of 2016, 256 retinal disease- 71 associated genes were identified for humans (https://sph.uth.edu/retnet/). Some of 72 these genes cause non-syndromic RP, whilst others contribute to syndromic disorders 73 such as Bardet-Biedl syndrome (BBS) (Hamel 2006). 4 74 Currently, retinal dystrophies in 58 domestic dog breeds have been linked to at least 25 75 mutations in 19 different genes (Miyadera et al. 2012; Downs et al. 2014b). Canine PRA 76 is typically inherited in an autosomal recessive pattern, although two forms that are X- 77 linked (Vilboux et al. 2008) and one that has dominant inheritance have been reported 78 (Kijas et al. 2002; Kijas et al. 2003). Many of these discoveries in the canine were made 79 using candidate gene studies, linkage mapping and genome-wide association studies 80 (GWAS) followed with fine mapping (Acland et al. 1999; Goldstein et al. 2006; 81 Kukekova et al. 2009; Downs et al. 2014b). This success has been facilitated by the 82 unique breeding structure of dogs. Intense artificial selection, genetic drift and strong 83 founder effects have resulted in stretches of linkage disequilibrium (LD) that can persist 84 for several megabases (Mb) within breeds, but only tens of kilobases across breeds 85 (Lindblad-Toh et al. 2005). This species population structure has allowed for the 86 successful mapping of Mendelian traits with fewer markers and subjects compared to 87 human gene mapping studies: as few as 10 unrelated cases and 10 controls (Karlsson 88 et al. 2007; Frischknecht et al. 2013; Jagannathan et al. 2013; Willet et al. 2015; Gerber 89 et al. 2015; Wolf et al. 2015). Such methods are accepted to work extremely well for 90 mapping monogenic traits that segregate within a single breed. 91 Despite this achievement, there are still many forms of PRA in several breeds of dog 92 that have yet to be genetically characterized. Traits with underlying genetic 93 heterogeneity and a late onset are notoriously difficult to map using linkage or GWAS 94 methods (Hirschhorn and Daly 2005; Korte and Farlow 2013). Although PRA is 95 collectively common, individually, specific forms are relatively rare and it may take many 96 generations until an adequately sized cohort of unrelated case samples are collected. 5 97 The genetic heterogeneity of PRA can complicate the results of linkage mapping and 98 GWAS, as different causative variants and genes can be responsible for an identical 99 phenotype. In addition, both linkage and GWAS rely on markers to be in LD and 100 segregate with the disease gene making it difficult to detect rare or de novo variants 101 (Hirschhorn and Daly 2005). 102 Since the advent of whole genome sequencing (WGS) and whole exome sequencing 103 (WES) technologies, the discovery of causal variants for rare or genetically 104 heterogeneous diseases has become more rapid with fewer case samples necessary 105 for success. One study design of note that has been used in human and more recently 106 in canine studies is the sequencing of parent-proband trios (Zhu et al. 2015; Sayyab et 107 al. 2016). As this method provides the chance for earlier diagnosis than previously 108 possible, this gives patients the opportunity to access more personalized treatment 109 options (Farwell et al. 2015; Zhu et al. 2015; Sawyer et al. 2016). 110 In a preliminary study, extensive screening of 53 genes associated with autosomal 111 recessive PRA or RP revealed no putative variants that could be associated with PRA in 112 the Hungarian Puli breed (Chew et al. 2017 [Animal Genetics in press]). Here, we 113 combine genotyping array data and WGS data of a parent-proband trio with an 114 additional half sibling case to identify a potentially novel canine PRA gene. We 115 successfully identify a highly associated mutation in exon 2 of BBS4 (c.58A>T, PCHISQ = 116 3.425e-14, n = 103) that segregates perfectly with the disease phenotype. This mutation 117 encodes a premature stop codon which is expected to result in complete loss of function 118 of the BBS4 protein. The association of BBS4 with canine PRA is a novel finding and 119 presents the first description of an associated variant for PRA in the Hungarian Puli. 6 120 Materials and Methods 121 Samples 122 This study involved 255 dogs (Canis lupus familiaris) that comprised 103 Hungarian Puli 123 and 152 Hungarian Pumi samples. This sample cohort included 14 Hungarian Pulis 124 segregating PRA in an autosomal recessive pattern from a previous study (Chew et al. 125 2017 [Animal Genetics in press]). Three affected Hungarian Pulis (USCF516, USCF519 126 and USCF1311) were diagnosed with PRA at the age of two years by registered 127 specialists in veterinary ophthalmology. Diagnosis was based on observed 128 ophthalmologic changes including vascular attenuation, hyper-reflectivity and reduced 129 myelination in the optic nerve head.
Recommended publications
  • Educational Paper Ciliopathies
    Eur J Pediatr (2012) 171:1285–1300 DOI 10.1007/s00431-011-1553-z REVIEW Educational paper Ciliopathies Carsten Bergmann Received: 11 June 2011 /Accepted: 3 August 2011 /Published online: 7 September 2011 # The Author(s) 2011. This article is published with open access at Springerlink.com Abstract Cilia are antenna-like organelles found on the (NPHP) . Ivemark syndrome . Meckel syndrome (MKS) . surface of most cells. They transduce molecular signals Joubert syndrome (JBTS) . Bardet–Biedl syndrome (BBS) . and facilitate interactions between cells and their Alstrom syndrome . Short-rib polydactyly syndromes . environment. Ciliary dysfunction has been shown to Jeune syndrome (ATD) . Ellis-van Crefeld syndrome (EVC) . underlie a broad range of overlapping, clinically and Sensenbrenner syndrome . Primary ciliary dyskinesia genetically heterogeneous phenotypes, collectively (Kartagener syndrome) . von Hippel-Lindau (VHL) . termed ciliopathies. Literally, all organs can be affected. Tuberous sclerosis (TSC) . Oligogenic inheritance . Modifier. Frequent cilia-related manifestations are (poly)cystic Mutational load kidney disease, retinal degeneration, situs inversus, cardiac defects, polydactyly, other skeletal abnormalities, and defects of the central and peripheral nervous Introduction system, occurring either isolated or as part of syn- dromes. Characterization of ciliopathies and the decisive Defective cellular organelles such as mitochondria, perox- role of primary cilia in signal transduction and cell isomes, and lysosomes are well-known
    [Show full text]
  • TRIM32 Is an E3 Ubiquitin Ligase for Dysbindin
    Human Molecular Genetics, 2009, Vol. 18, No. 13 2344–2358 doi:10.1093/hmg/ddp167 Advance Access published on April 6, 2009 TRIM32 is an E3 ubiquitin ligase for dysbindin Matthew Locke1,2, Caroline L. Tinsley1, Matthew A. Benson2,{ and Derek J. Blake1,Ã 1Department of Psychological Medicine, Cardiff University, Henry Wellcome Building for Biomedical Research in Wales, Heath Park, Cardiff, CF14 4XN, UK and 2Department of Pharmacology, University of Oxford, Mansfield Road, Oxford OX1 3QT, UK Received December 15, 2008; Revised and Accepted April 2, 2009 Mutations in the gene encoding tripartite motif protein 32 (TRIM32) cause two seemingly diverse diseases: limb-girdle muscular dystrophy type 2H (LGMD2H) or sarcotubular myopathy (STM) and Bardet–Biedl syndrome type 11(BBS11). Although TRIM32 is involved in protein ubiquitination, its substrates and the molecular consequences of disease-causing mutations are poorly understood. In this paper, we show that Downloaded from TRIM32 is a widely expressed ubiquitin ligase that is localized to the Z-line in skeletal muscle. Using the yeast two-hybrid system, we found that TRIM32 binds and ubiquitinates dysbindin, a protein implicated in the genetic aetiology of schizophrenia, augmenting its degradation. Small-interfering RNA-mediated knock-down of TRIM32 in myoblasts resulted in elevated levels of dysbindin. Importantly, the LGMD2H/ STM-associated TRIM32 mutations, D487N and R394H impair ubiquitin ligase activity towards dysbindin http://hmg.oxfordjournals.org/ and were mislocalized in heterologous cells. These mutants were able to self-associate and also co-immuno- precipitated with wild-type TRIM32 in transfected cells. Furthermore, the D487N mutant could bind to both dysbindin and its E2 enzyme but was defective in monoubiquitination.
    [Show full text]
  • Monogenic Causation in Chronic Kidney Disease
    University of Dublin, Trinity College School of Medicine, Department of Medicine Investigation of the monogenic causes of chronic kidney disease PhD Thesis April 2020 Dervla Connaughton Supervisor: Professor Mark Little Co-Supervisors: Professor Friedhelm Hildebrandt and Professor Peter Conlon 1 DECLARATION I declare that this thesis has not been submitted as an exercise for a degree at this or any other university and it is entirely my own work. This work was funding by the Health Research Board, Ireland (HPF-206-674), the International Pediatric Research Foundation Early Investigators’ Exchange Program and the Amgen® Irish Nephrology Society Specialist Registrar Bursary. I agree to deposit this thesis in the University’s open access institutional repository or allow the Library to do so on my behalf, subject to Irish Copyright Legislation and Trinity College Library conditions of use and acknowledgement. I consent to the examiner retaining a copy of the thesis beyond the examining period, should they so wish (EU GDPR May 2018). _____________________ Dervla Connaughton 2 SUMMARY Chapter 1 provides an introduction to the topic while Chapter 2 provides details of the methods employed in this work. In Chapter 3 I provide an overview of the currently known monogenic causes for human chronic kidney disease (CKD). I also describe how next- generation sequencing can facilitate molecular genetic diagnostics in individuals with suspected genetic kidney disease. Chapter 4 details the findings of a multi-centre, cross-sectional study of patients with CKD in the Republic of Ireland. The primary aim of this study (the Irish Kidney Gene Project) was to describe the prevalence of reporting a positive family history of CKD among a representation sample of the CKD population.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Diagnostic Test: OBESITÀ GENETICHE MENDELIANE
    Diagnostic test: OBESITÀ GENETICHE MENDELIANE MENDELIAN OBESITY Panel / Illumina Custom panel, Nextera Enrichment Technology / Coding exons and flanking regions of genes List of gene(s) and disease(s) tested: ALMS1, ARL6, BBIP1, BBS1, BBS10, BBS12, BBS2, BBS4, BBS5, BBS7, BBS9, C8orf37, CARTPT, CEP19, CEP290, DYRK1B, GNAS, HDAC8, IFT172, IFT27, INPP5E, INSR, KSR2, LEP, LEPR, LZTFL1, MC3R, MC4R, MCHR1, MEGF8, MKKS, MKS1, NR0B2, PCSK1, PHF6, POMC, PPARG, PPP1R3A, RAB23, SDCCAG8, SH2B1, SIM1, TRIM32, TTC8, UCP3, VPS13B, WDPCP ORPHA:98267 Obesità non sindromica genetica Obesità sindromica Tabella Elenco delle forme di OBESITÀ GENETICHE MENDELIANE e la loro eziologia genetica Phenotype OMIM# Gene OMIM# Phenotype Gene Alstrom syndrome 203800 ALMS1 606844 Bardet-Biedl syndrome 3 600151 ARL6 608845 Bardet-Biedl syndrome 18 615995 BBIP1 613605 Bardet-Biedl syndrome 1 209900 BBS1 209901 Bardet-Biedl syndrome 10 615987 BBS10 610148 Bardet-Biedl syndrome 12 615989 BBS12 610683 Bardet-Biedl syndrome 2 615981 BBS2 606151 Bardet-Biedl syndrome 4 615982 BBS4 600374 Bardet-Biedl syndrome 5 615983 BBS5 603650 Bardet-Biedl syndrome 7 615984 BBS7 607590 Bardet-Biedl syndrome 21 617406 C8orf37 614477 Obesity, severe HGMD CARTPT 602606 Morbid obesity and spermatogenic failure; Bardet-Biedl syndrome; Morbid obesity 615703; HGMD CEP19 615586 Bardet-Biedl syndrome 14 615991 CEP290 610142 Abdominal obesity-metabolic syndrome 3 615812 DYRK1B 604556 Pseudohypoparathyroidism Ia; Pseudohypoparathyroidism Ic 103580; 612462 GNAS 139320 Cornelia de Lange syndrome 5 300882
    [Show full text]
  • The Role of Primary Cilia in the Crosstalk Between the Ubiquitin–Proteasome System and Autophagy
    cells Review The Role of Primary Cilia in the Crosstalk between the Ubiquitin–Proteasome System and Autophagy Antonia Wiegering, Ulrich Rüther and Christoph Gerhardt * Institute for Animal Developmental and Molecular Biology, Heinrich Heine University, 40225 Düsseldorf, Germany; [email protected] (A.W.); [email protected] (U.R.) * Correspondence: [email protected]; Tel.: +49-(0)211-81-12236 Received: 29 December 2018; Accepted: 11 March 2019; Published: 14 March 2019 Abstract: Protein degradation is a pivotal process for eukaryotic development and homeostasis. The majority of proteins are degraded by the ubiquitin–proteasome system and by autophagy. Recent studies describe a crosstalk between these two main eukaryotic degradation systems which allows for establishing a kind of safety mechanism. If one of these degradation systems is hampered, the other compensates for this defect. The mechanism behind this crosstalk is poorly understood. Novel studies suggest that primary cilia, little cellular protrusions, are involved in the regulation of the crosstalk between the two degradation systems. In this review article, we summarise the current knowledge about the association between cilia, the ubiquitin–proteasome system and autophagy. Keywords: protein aggregation; neurodegenerative diseases; OFD1; BBS4; RPGRIP1L; hedgehog; mTOR; IFT; GLI 1. Introduction Protein aggregates are huge protein accumulations that develop as a consequence of misfolded proteins. The occurrence of protein aggregates is associated with the development of neurodegenerative diseases, such as Huntington’s disease, prion disorders, Alzheimer’s disease and Parkinson’s disease [1–3], demonstrating that the degradation of incorrectly folded proteins is of eminent importance for human health. In addition to the destruction of useless and dangerous proteins (protein quality control), protein degradation is an important process to regulate the cell cycle, to govern transcription and also to control intra- and intercellular signal transduction [4–6].
    [Show full text]
  • Supplementary Table S4. FGA Co-Expressed Gene List in LUAD
    Supplementary Table S4. FGA co-expressed gene list in LUAD tumors Symbol R Locus Description FGG 0.919 4q28 fibrinogen gamma chain FGL1 0.635 8p22 fibrinogen-like 1 SLC7A2 0.536 8p22 solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 DUSP4 0.521 8p12-p11 dual specificity phosphatase 4 HAL 0.51 12q22-q24.1histidine ammonia-lyase PDE4D 0.499 5q12 phosphodiesterase 4D, cAMP-specific FURIN 0.497 15q26.1 furin (paired basic amino acid cleaving enzyme) CPS1 0.49 2q35 carbamoyl-phosphate synthase 1, mitochondrial TESC 0.478 12q24.22 tescalcin INHA 0.465 2q35 inhibin, alpha S100P 0.461 4p16 S100 calcium binding protein P VPS37A 0.447 8p22 vacuolar protein sorting 37 homolog A (S. cerevisiae) SLC16A14 0.447 2q36.3 solute carrier family 16, member 14 PPARGC1A 0.443 4p15.1 peroxisome proliferator-activated receptor gamma, coactivator 1 alpha SIK1 0.435 21q22.3 salt-inducible kinase 1 IRS2 0.434 13q34 insulin receptor substrate 2 RND1 0.433 12q12 Rho family GTPase 1 HGD 0.433 3q13.33 homogentisate 1,2-dioxygenase PTP4A1 0.432 6q12 protein tyrosine phosphatase type IVA, member 1 C8orf4 0.428 8p11.2 chromosome 8 open reading frame 4 DDC 0.427 7p12.2 dopa decarboxylase (aromatic L-amino acid decarboxylase) TACC2 0.427 10q26 transforming, acidic coiled-coil containing protein 2 MUC13 0.422 3q21.2 mucin 13, cell surface associated C5 0.412 9q33-q34 complement component 5 NR4A2 0.412 2q22-q23 nuclear receptor subfamily 4, group A, member 2 EYS 0.411 6q12 eyes shut homolog (Drosophila) GPX2 0.406 14q24.1 glutathione peroxidase
    [Show full text]
  • Renal Cystic Disorders Infosheet 6-14-19
    Next Generation Sequencing Panel for Renal Cystic Disorders Clinical Features: Renal cystic diseases are a genetically heterogeneous group of conditions characterized By isolated renal disease or renal cysts in conjunction with extrarenal features (1). Age of onset of renal cystic disease ranges from neonatal to adult onset. Common features of renal cystic diseases include renal insufficiency and progression to end stage renal disease (ESRD). Identification of the genetic etiology of renal cystic disease can aid in appropriate clinical management of the affected patient. Our Renal Cystic Disorders Panel includes sequence and deletion/duplicaton analysis of all 79 genes listed below. Renal Cystic Disorders Sequencing Panel AHI1 BMPER HNF1B NEK8 TCTN3 WDPCP ANKS6 C5orf42 IFT27 NOTCH2 TFAP2A WDR19 ARL13B CC2D2A IFT140 NPHP1 TMEM107 XPNPEP3 ARL6 CDC73 IFT172 NPHP3 TMEM138 ZNF423 B9D1 CEP104 INPP5E NPHP4 TMEM216 B9D2 CEP120 INVS OFD1 TMEM231 BBIP1 CEP164 IQCB1 PDE6D TMEM237 BBS1 CEP290 JAG1 PKD2 TMEM67 BBS10 CEP41 KIAA0556 PKHD1 TRIM32 BBS12 CEP83 KIAA0586 REN TSC1 BBS2 CRB2 KIF14 RPGRIP1L TSC2 BBS4 CSPP1 KIF7 SALL1 TTC21B BBS5 DCDC2 LZTFL1 SDCCAG8 TTC8 BBS7 GLIS2 MKKS TCTN1 UMOD BBS9 GLIS3 MKS1 TCTN2 VHL Disorder Genes Inheritance Clinical features/molecular genetics Bardet Biedl ARL6 AR Bardet-Biedl syndrome (BBS) is an autosomal syndrome BBS1 recessive multi-systemic ciliopathy characterized By BBS10 retinal dystrophy, oBesity, postaxial polydactyly, BBS12 leaning difficulties, renal involvement and BBS2 genitourinary abnormalities (2). Visual prognosis is BBS4 poor, and the mean age of legal Blindness is 15.5 BBS5 years. Birth weight is typically normal But significant BBS7 weight gain Begins within the first year. Renal BBS9 disease is a major cause of morBidity and mortality.
    [Show full text]
  • Mouse Mutants As Models for Congenital Retinal Disorders
    Experimental Eye Research 81 (2005) 503–512 www.elsevier.com/locate/yexer Review Mouse mutants as models for congenital retinal disorders Claudia Dalke*, Jochen Graw GSF-National Research Center for Environment and Health, Institute of Developmental Genetics, D-85764 Neuherberg, Germany Received 1 February 2005; accepted in revised form 1 June 2005 Available online 18 July 2005 Abstract Animal models provide a valuable tool for investigating the genetic basis and the pathophysiology of human diseases, and to evaluate therapeutic treatments. To study congenital retinal disorders, mouse mutants have become the most important model organism. Here we review some mouse models, which are related to hereditary disorders (mostly congenital) including retinitis pigmentosa, Leber’s congenital amaurosis, macular disorders and optic atrophy. q 2005 Elsevier Ltd. All rights reserved. Keywords: animal model; retina; mouse; gene mutation; retinal degeneration 1. Introduction Although mouse models are a good tool to investigate retinal disorders, one should keep in mind that the mouse Mice suffering from hereditary eye defects (and in retina is somehow different from a human retina, particular from retinal degenerations) have been collected particularly with respect to the number and distribution of since decades (Keeler, 1924). They allow the study of the photoreceptor cells. The mouse as a nocturnal animal molecular and histological development of retinal degener- has a retina dominated by rods; in contrast, cones are small ations and to characterize the genetic basis underlying in size and represent only 3–5% of the photoreceptors. Mice retinal dysfunction and degeneration. The recent progress of do not form cone-rich areas like the human fovea.
    [Show full text]
  • Modeling Ciliopathies: Primary Cilia in Development and Disease
    CHAPTER FIVE Modeling Ciliopathies: Primary Cilia in Development and Disease Robyn J. Quinlan, Jonathan L. Tobin, and Philip L. Beales Contents 1. The Human Ciliopathies 250 2. Bardet-Biedl Syndrome 251 3. Alstro¨m Syndrome 263 4. Polycystic Kidney Disease 264 5. Nephronophthisis 265 6. Meckel Syndrome 267 7. Joubert Syndrome 268 8. Jeune Syndrome 269 9. Oral–Facial–Digital Syndrome 269 10. The Structure and Function of the Cilium 270 10.1. The structure of primary cilia 270 10.2. Intraflagellar transport 272 10.3. IFT and ciliopathies 272 11. Cilia and Development 276 11.1. Left–right determination 276 11.2. Hedgehog signaling in ciliopathies 277 11.3. Cilia and polarity 280 11.4. Cilia and cystogenesis in mammals 283 11.5. Cilia and obesity 286 12. Therapies for Cystic Disease 287 13. Concluding Remarks 289 References 292 Abstract Primary (nonmotile) cilia are currently enjoying a renaissance in light of novel ascribed functions ranging from mechanosensory to signal transduction. Their importance for key developmental pathways such as Sonic Hedgehog (Shh) and Wnt is beginning to emerge. The function of nodal cilia, for example, is vital for Molecular Medicine Unit, Institute of Child Health, University College London, London, WC1N1EH, United Kingdom Current Topics in Developmental Biology, Volume 84 # 2008 Elsevier Inc. ISSN 0070-2153, DOI: 10.1016/S0070-2153(08)00605-4 All rights reserved. 249 250 Robyn J. Quinlan et al. breaking early embryonic symmetry, Shh signaling is important for tissue morphogenesis and successful Wnt signaling for organ growth and differentia- tion. When ciliary function is perturbed, photoreceptors may die, kidney tubules develop cysts, limb digits multiply and brains form improperly.
    [Show full text]
  • Perkinelmer Genomics to Request the Saliva Swab Collection Kit for Patients That Cannot Provide a Blood Sample As Whole Blood Is the Preferred Sample
    Eye Disorders Comprehensive Panel Test Code D4306 Test Summary This test analyzes 211 genes that have been associated with ocular disorders. Turn-Around-Time (TAT)* 3 - 5 weeks Acceptable Sample Types Whole Blood (EDTA) (Preferred sample type) DNA, Isolated Dried Blood Spots Saliva Acceptable Billing Types Self (patient) Payment Institutional Billing Commercial Insurance Indications for Testing Individuals with an eye disease suspected to be genetic in origin Individuals with a family history of eye disease Individuals suspected to have a syndrome associated with an eye disease Test Description This panel analyzes 211 genes that have been associated with ocular disorders. Both sequencing and deletion/duplication (CNV) analysis will be performed on the coding regions of all genes included (unless otherwise marked). All analysis is performed utilizing Next Generation Sequencing (NGS) technology. CNV analysis is designed to detect the majority of deletions and duplications of three exons or greater in size. Smaller CNV events may also be detected and reported, but additional follow-up testing is recommended if a smaller CNV is suspected. All variants are classified according to ACMG guidelines. Condition Description Diseases associated with this panel include microphtalmia, anophthalmia, coloboma, progressive external ophthalmoplegia, optic nerve atrophy, retinal dystrophies, retinitis pigementosa, macular degeneration, flecked-retinal disorders, Usher syndrome, albinsm, Aloprt syndrome, Bardet Biedl syndrome, pulmonary fibrosis, and Hermansky-Pudlak
    [Show full text]
  • BBS1 Mutations in a Wide Spectrum of Phenotypes Ranging from Nonsyndromic Retinitis Pigmentosa to Bardet-Biedl Syndrome
    OPHTHALMIC MOLECULAR GENETICS SECTION EDITOR: JANEY L. WIGGS, MD, PhD BBS1 Mutations in a Wide Spectrum of Phenotypes Ranging From Nonsyndromic Retinitis Pigmentosa to Bardet-Biedl Syndrome Alejandro Estrada-Cuzcano, BSc; Robert K. Koenekoop, MD, PhD; Audrey Senechal, PhD; Elfride B. W. De Baere, MD, PhD; Thomy de Ravel, MD, PhD; Sandro Banfi, MD; Susanne Kohl, MD; Carmen Ayuso, MD, PhD; Dror Sharon, PhD; Carel B. Hoyng, MD; Christian P. Hamel, MD, PhD; Bart P. Leroy, MD, PhD; Carmela Ziviello, BS; Irma Lopez, PhD; Alexandre Bazinet, MD; Bernd Wissinger, PhD; Ieva Sliesoraityte, MD; Almudena Avila-Fernandez, PhD; Karin W. Littink, MD, PhD; Enzo M. Vingolo, MD; Sabrina Signorini, MD, PhD; Eyal Banin, MD, PhD; Liliana Mizrahi-Meissonnier, PhD; Eberhard Zrenner, MD; Ulrich Kellner, MD; Rob W. J. Collin, PhD; Anneke I. den Hollander, PhD; Frans P. M. Cremers, PhD; B. Jeroen Klevering, MD, PhD Objective: To investigate the involvement of the Bardet- 2 BBS1 variants showed the entire clinical spectrum, from Biedl syndrome (BBS) gene BBS1 p.M390R variant in non- nonsyndromic RP to full-blown BBS. In 8 of 14 patients, syndromic autosomal recessive retinitis pigmentosa (RP). visual acuity was significantly reduced. In patients with electroretinographic responses, a rod-cone pattern of pho- Methods: Homozygosity mapping of a patient with iso- toreceptor degeneration was observed. lated RP was followed by BBS1 sequence analysis. We per- formed restriction fragment length polymorphism analy- Conclusions: Variants in BBS1 are significantly associ- sis of the p.M390R allele in 2007 patients with isolated ated with nonsyndromic autosomal recessive RP and rela- RP or autosomal recessive RP and in 1824 ethnically tively mild forms of BBS.
    [Show full text]